Literature DB >> 3680873

McCune-Albright syndrome with gigantism and hyperprolactinemia.

F Pacini1, G Perri, P Bagnolesi, A Cilotti, A Pinchera.   

Abstract

We describe the case of a 38-year-old man with typical Mc Cune-Albright syndrome and the unusual combination of both growth-hormone and prolactin hypersecretion. The patient was extremely tall, which is unusual in Mc Cune-Albright syndrome, suggesting that he did not have precocious fusion of the epiphysis, a common finding in this syndrome. Unfortunately the patient refused any treatment for his disease. A similar case has been previously described only in a 14-year-old boy.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3680873     DOI： 10.1007/BF03348161

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


  7 in total

1.  POLYOSTOTIC FIBROUS DYSPLASIA AND ACROMEGALY.

Authors:  M T SCURRY; J M BICKNELL; S S FAJANS
Journal:  Arch Intern Med       Date:  1964-07

2.  McCune-Albright's syndrome following adrenalectomy for Cushing's syndrome in infancy.

Authors:  D Aarskog; E Tveteraas
Journal:  J Pediatr       Date:  1968-07       Impact factor: 4.406

3.  The spectrum of pituitary growth hormone responses to pharmacological stimuli in acromegaly.

Authors:  K Hanew; M Kokubun; A Sasaki; T Mouri; K Yoshinaga
Journal:  J Clin Endocrinol Metab       Date:  1980-08       Impact factor: 5.958

4.  Gigantism and hyperprolactinemia in polyostotic fibrous dysplasia (Mc Cune--Albright syndrome).

Authors:  C Polychronakos; G Tsoukas; J R Ducharme; J Letarte; R Collu
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

5.  Sex precocity and polyostotic fibrous dysplasia. Report of a case in a boy with testicular biopsy.

Authors:  P H Benedict
Journal:  Am J Dis Child       Date:  1966-04

6.  Polyostotic fibrous dysplasia with thyrotoxicosis. Report of a complete autopsy and skeletal reconstruction.

Authors:  M Moldawer; E R Rabin
Journal:  Arch Intern Med       Date:  1966-10

7.  Hypersecretion of hypothalamic releasing hormones: a possible explanation of the endocrine manifestations of polyostotic fibrous dysplasia (Albright's syndrome).

Authors:  R Hall; C Warrick
Journal:  Lancet       Date:  1972-06-17       Impact factor: 79.321
  7 in total
  5 in total

1.  Polyostotic fibrous dysplasia with gigantism and huge pelvic tumor: a rare case of McCune-Albright syndrome.

Authors:  Kenshi Sakayama; Yoshifumi Sugawara; Teruki Kidani; Taketsugu Fujibuchi; Katsumi Kito; Nozomu Tanji; Atsushi Nakamura
Journal:  Int J Clin Oncol       Date:  2010-09-29       Impact factor: 3.402

2.  Octreotide therapy of growth hormone excess in the McCune-Albright syndrome.

Authors:  S I Sherman; P W Ladenson
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

3.  McCune-Albright syndrome. A case of primary hypogonadism obscured by hyperprolactinemic hypogonadotropic hypogonadism.

Authors:  A L Swislocki; C A Camargo; A R Hoffman
Journal:  West J Med       Date:  1990-12

Review 4.  Acromegaly and McCune-Albright syndrome.

Authors:  Sylvie Salenave; Alison M Boyce; Michael T Collins; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2014-02-11       Impact factor: 5.958

5.  Effects of cyproterone acetate, LHRH agonist and ovarian surgery in McCune-Albright syndrome with precocious puberty and galactorrhea.

Authors:  C Carani; C Pacchioni; A Baldini; D Zini
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.